Mental health platform Lissun in India secures $2.5 million in funding to integrate AI into their mental health solutions. Asan Medical Center in South Korea starts prescribing a digital therapeutic for stroke-related vision loss. Neurophet partners with Aribio to develop a new Alzheimer’s diagnosis platform, combining MRI-based image analysis with a blood-based diagnostic test. This collaboration aims to improve accessibility to Alzheimer’s testing and reduce costs. Neurophet also recently launched the Neurophet AQUA AD, its latest Alzheimer’s treatment prescription and monitoring software.
Source link
Indian mental health app Lissun takes on AI with $3M and more briefs
